<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>"Traveller's <z:mp ids='MP_0005048'>thrombosis</z:mp>" is defined as a <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> of the leg that develops no later than two weeks following a journey lasting at least five hours </plain></SENT>
<SENT sid="1" pm="."><plain>According to the WHO, traveller's <z:mp ids='MP_0005048'>thrombosis</z:mp> affects in particular persons with additional risk factors </plain></SENT>
<SENT sid="2" pm="."><plain>These include <z:hpo ids='HP_0001513'>obesity</z:hpo>, age, such prior diseases as <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumours</z:e>, previous surgery, use of oral contraceptives, and such inborn risk factors as <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> and <z:e sem="disease" ids="C0584983" disease_type="Disease or Syndrome" abbrv="">homozygous factor V Leiden mutation</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In such patients, the (air) journey is merely the triggering event </plain></SENT>
<SENT sid="4" pm="."><plain>Prophylactic measures should include counseling of high-risk patients </plain></SENT>
<SENT sid="5" pm="."><plain>Depending on the risk profile, recommended general measures are compression and low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The much discussed use of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi>, in contrast, is no certain prophylaxis </plain></SENT>
</text></document>